Delivery Order SPE2DB24D9238-SPE2DB25FDRAK
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,181.70 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. The contract calls for the delivery of ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine, with an ultimate completion date of August 14, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 18, 2025, for ENGERIX-B pediatric hepatitis B vaccine (10 micrograms/0.5 milliliter syringes). This firm fixed-price delivery order carries a ceiling value of $4,243.68 and is scheduled for completion by July 21, 2025. The contract utilizes no set-aside designation, and performance will occur at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,878.00 by the Defense Logistics Agency's Medical Supply Chain on August 5, 2025, for the supply of ENGERIX-B 20 MCG/ML syringes. This firm fixed-price delivery order, which carries an ultimate completion date of August 8, 2025, represents a discrete procurement action under the company's existing Indefinite Delivery Contract with DLA....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,607.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, carries a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,121.84 to DMS Pharmaceutical Group Inc. for the supply of ENGERIX-B PEDI 10 MCG/0.5 syringe in 0.5 milliliter quantities. The award was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at...
- The Defense Logistics Agency issued a delivery order valued at $8,184.24 to DMS Pharmaceutical Group Inc. for ENGERIX-B PEDI 10 MCG/0.5 syringe pediatric hepatitis B vaccine on August 19, 2025, with completion expected by August 20, 2025. This firm fixed-price delivery order was awarded without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The vaccine will be delivered to the Park Ridge location and represents a routine...
- This delivery order for $2,362.08 was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine, to the Defense Logistics Agency (DLA) Medical Supply Chain. The order, placed under the DLA's SPE2DB program, has a firm fixed price and an ultimate completion date of July 12, 2024. DMS Pharmaceutical Group specializes in providing a wide range...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,233.20 for Hepatitis B Virus vaccine by the Defense Logistics Agency (DLA), operating under the Medical Supply Chain function. This delivery order, issued on August 7, 2025, with an ultimate completion date of the same day, represents a task order issued under DMS Pharmaceutical Group's larger single-award Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,969.50 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. The IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,603.16 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, with no set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDRAKDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,578.00 by the Defense Logistics Agency (DLA) on September 9, 2025, with an ultimate completion date of September 10, 2025. The contract is for the supply of ENGERIX-B PEDI 10 MCG/0.5 syringe vaccines in 0.5 milliliter quantities. This delivery order utilizes firm fixed-price pricing and was issued without a set-aside designation, leveraging the vendor's competitive position as a small business in federal procurement. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its operations. This award represents a delivery order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. The IDC enables the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of contracts covering branded and generic prescription drugs, biologics, vaccines, and medical consumables. This specific delivery order for pediatric hepatitis B vaccine reflects the company's ongoing role in supplying essential medical products to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 9/9/25 |